CATERPILLAR™ Arterial Embolization Device Study — CHRYSALIS

Embolization, Therapeutic Clinical Trial

Official title:
A Prospective, Multi-Center, Single-Arm Study Assessing the Clinical Use of the CATERPILLAR™ Arterial Embolization Device System for Arterial Embolization in the Peripheral Vasculature (CHRYSALIS)

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the performance and safety of the CATERPILLAR™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature.

Clinical Trial Description

This feasibility study is a prospective, multi-center, single-arm study of the CATERPILLAR™ Arterial Embolization Device. Up to twenty (20) subjects will be treated with the CATERPILLAR™ Arterial Embolization Device at up to 5 investigational sites in New Zealand and Australia. ;

Study Design

Related Conditions & MeSH terms

Embolization, Therapeutic

Clinical Trial Details

NCT number	NCT04090320
Study type	Interventional
Source	C. R. Bard
Contact
Status	Completed
Phase	N/A
Start date	September 25, 2019
Completion date	November 4, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05531240` - Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)	N/A
Recruiting	`NCT04115137` - Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC
Recruiting	`NCT03853434` - Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.	N/A
Not yet recruiting	`NCT03805087` - Transarterial Coil Embolization of the Superior Rectal Arteries for Treatment of Stage II Hemorrhoids	N/A
Completed	`NCT04244370` - Caterpillar™ Arterial Embolization Device Post-Market Study	N/A